Ocumension Therapeutics (1477.HK)

HKD 5.45

(8.57%)

Net Debt Summary of Ocumension Therapeutics

Ocumension Therapeutics's latest annual net debt in 2023 was -704.85 Million CNY , up 38.2% from previous year.
Ocumension Therapeutics's latest quarterly net debt in 2023 FY was -704.85 Million CNY , up 38.2% from previous quarter.
Ocumension Therapeutics reported annual net debt of -1.14 Billion CNY in 2022, down -2.38% from previous year.
Ocumension Therapeutics reported annual net debt of -1.11 Billion CNY in 2021, up 45.04% from previous year.
Ocumension Therapeutics reported quarterly net debt of -704.85 Million CNY for 2023 Q4, up 24.06% from previous quarter.
Ocumension Therapeutics reported quarterly net debt of -512.58 Million CNY for 2023 Q2, up 50.16% from previous quarter.

Annual Net Debt Chart of Ocumension Therapeutics (2023 - 2018)

Historical Annual Net Debt of Ocumension Therapeutics (2023 - 2018)

Year	Net Debt	Net Debt Growth
2023	-704.85 Million CNY	38.2%
2022	-1.14 Billion CNY	-2.38%
2021	-1.11 Billion CNY	45.04%
2020	-2.02 Billion CNY	-960.49%
2019	-191.14 Million CNY	-680.09%
2018	-24.5 Million CNY	0.0%

Year	Net Debt	Net Debt Growth
2023 Q1	-1.02 Billion CNY	9.82%
2023 Q4	-704.85 Million CNY	24.06%
2023 Q2	-512.58 Million CNY	50.16%
2023 Q3	-928.14 Million CNY	-81.07%
2023 FY	-704.85 Million CNY	38.2%
2022 Q1	-1.54 Billion CNY	-39.11%
2022 Q4	-1.14 Billion CNY	12.08%
2022 Q3	-1.29 Billion CNY	15.32%
2022 Q2	-1.53 Billion CNY	1.16%
2022 FY	-1.14 Billion CNY	-2.38%
2021 Q1	-2.27 Billion CNY	-12.23%
2021 FY	-1.11 Billion CNY	45.04%
2021 Q3	-1.77 Billion CNY	20.85%
2021 Q2	-2.24 Billion CNY	1.25%
2021 Q4	-1.11 Billion CNY	37.35%
2020 Q3	-2.04 Billion CNY	-171.17%
2020 Q4	-2.02 Billion CNY	0.95%
2020 FY	-2.02 Billion CNY	-960.49%
2020 Q1	4.07 Billion CNY	2231.97%
2020 Q2	-754.68 Million CNY	-118.52%
2019 Q1	91.89 Million CNY	0.0%
2019 Q4	-191.14 Million CNY	-107.44%
2019 Q3	2.56 Billion CNY	0.0%
2019 FY	-191.14 Million CNY	-680.09%
2018 FY	-24.5 Million CNY	0.0%

Peer Net Debt Comparison of Ocumension Therapeutics

Name	Net Debt	Net Debt Difference
Uni-Bio Science Group Limited	-76.36 Million HKD	-822.961%
CK Life Sciences Int'l., (Holdings) Inc.	5.26 Billion HKD	113.383%